HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NICEATM request

This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program Interagency Center on Evaluation of Alternative Toxicological Methods requests nominations for scientists to sit on expert panel that will evaluate the validation status of two in vitro cytotoxicity assays for estimating in vivo acute oral toxicity in March 22 Federal Register 1notice. ICCVAM would consider the panel's conclusions in developing test method recommendations and performance standards, agency adds. Nominations should be sent to NICEATM Director William Stokes by May 6. NICEATM also is requesting data on standard in vivo acute oral toxicity and in vitro cytotoxicity tests. Agency announced the availability of the test protocols in October (2The Rose Sheet" Oct. 25, 2004, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel